Metropolitan Life Insurance Company (MetLife)’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,436
| Closed | -$81.4K | – | 2592 |
|
|
2020
Q3 | $81.4K | Buy |
+4,436
| New | +$81.4K | ﹤0.01% | 2338 |
|
|
2020
Q2 | – | Sell |
-4,384
| Closed | -$69.4K | – | 2623 |
|
|
2020
Q1 | $69.4K | Buy |
+4,384
| New | +$69.4K | ﹤0.01% | 2254 |
|
|
2019
Q1 | – | Sell |
-4,573
| Closed | -$80.8K | – | 2585 |
|
|
2018
Q4 | $80.8K | Buy |
+4,573
| New | +$80.8K | ﹤0.01% | 2407 |
|
|
2016
Q2 | – | Sell |
-8,651
| Closed | -$161K | – | 2703 |
|
|
2016
Q1 | $161K | Buy |
8,651
+705
| +9% | +$13.1K | ﹤0.01% | 2300 |
|
|
2015
Q4 | $171K | Sell |
7,946
-995
| -11% | -$21.4K | ﹤0.01% | 2361 |
|
|
2015
Q3 | $151K | Buy |
8,941
+78
| +0.9% | +$1.32K | ﹤0.01% | 2469 |
|
|
2015
Q2 | $332K | Buy |
+8,863
| New | +$332K | ﹤0.01% | 2053 |
|